<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://pharmadog.xyz/news/134233</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:38:00.000Z</news:publication_date>
      <news:title>CLINUVEL to cut up to 20% of staff and move headquarters to New York</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/687527</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:25:43.000Z</news:publication_date>
      <news:title>Apple and OpenEvidence Begin Study of Experimental AI Health Chat App</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/685563</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-15T14:03:30.000Z</news:publication_date>
      <news:title>FDA denies Summit Therapeutics&apos; ivonescimab for EGFR-mutated lung cancer, halting US entry</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/685095</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-15T12:56:23.000Z</news:publication_date>
      <news:title>FDA rejects Summit and Akeso&apos;s ivonescimab for narrow lung cancer</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/680483</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T11:00:31.000Z</news:publication_date>
      <news:title>George Church departs AI startup as Ira Mellman advances immunotherapy efforts</news:title>
    </news:news>
  </url>
</urlset>
